Examining FDA Regulation: A Checkup with House Energy and Commerce Committee Chairs

In a recent statement, House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) announced a hearing titled “Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices.” The Chairs emphasized the importance of engaging regularly with FDA officials to understand what is working well and what challenges persist, especially with the increased funding provided in the most recent user fee reauthorization.

The Subcommittee on Health hearing will take place on Wednesday, May 22, 2024 at 10:30 AM ET at 2322 Rayburn House Office Building. The hearing will focus on discussing the FDA’s regulation of drugs, biologics, and devices.

Witnesses at the hearing will include Dr. Patrizia Cavazzoni, Director of the Center for Drug Evaluation and Research (CDER) at the FDA, Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA, and Dr. Jeffrey Shuren, Director of the Center for Devices and Radiological Health (CDRH) at the FDA. The hearing will be open to the public and press